General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a woman having injectionApril 11 2018

A community pharmacy is providing a Xolair (omalizumab) injection service for asthma patients, with nurses delivering the sub-cutaneous injections. 

The service has been launched at a LloydsPharmacy Healthcare Centre based in Scunthorpe, North Lincolnshire, in partnership with Northern Lincolnshire and Goole NHS Foundation Trust (NLaG). It means patients can now go to the community pharmacy rather than the hospital for the injection every four weeks.

The injection is intended to reduce sensitivity to allergens and can be used to try to control severe allergic asthma which does not respond to high doses of corticosteroids, as well as being used in chronic spontaneous urticaria.

LloydsPharmacy’s parent company Celesio UK launched its Healthcare Centres programme last year, with the aim of working with hospitals to deliver treatments in the community instead of an acute care setting. Other Healthcare Centres services include working with the Greater Manchester Cancer Vanguard to spot signs of cancer earlier and a pharmacist-delivered osteoporosis injection service (Denosumab) in the West Midlands.

LloydsPharmacy has been working with NLaG NHS Foundation Trust for a number of year and runs an outpatient service from the community pharmacy in Goole, serving the Goole and District Hospital. It also has outpatient hospital pharmacy dispensaries at the Scunthorpe General Hospital and Diana, Princess of Wales Hospital in Grimsby. 

Andy Burton, director of community services at Celesio UK, said: “This has been a good basis on which to build our relationship and evolve new services that deliver efficiencies for the Trust.

“Our new immunology service was co-designed with referring clinical teams and consultants and allows patients to have their specialist medicines administered by a trained LloydsPharmacy Clinical Homecare (LPCH) nurse in a pharmacy clinic setting. Patients that are deemed appropriate by their consultant can now opt to receive this injection in their local community which can be more convenient as well as saving them time and money.”

Paul Fieldhouse, chief pharmacist and clinical lead for medicines optimisation at NLaG NHS Foundation Trust, said: “This new innovative service is a great example of collaboration between hospitals and community pharmacy to deliver a new service to meet patients’ requirements. It’s great to see Scunthorpe General Hospital at the forefront of developing new services in the NHS.”

Paulash Haider, lead pharmacist medication safety and procurement at Northern Lincolnshire and Goole NHS Foundation Trust, added: “This arrangement is a real positive for the Trust. It’s an integrated approach to working which allows more specialist areas to be focused on by our staff in the hospital.

“There are patients who we treat who require greater clinical contact time and, as a result of this cooperative engagement programme, we’ll be able to offer this.”

Links:
Celesio UK       

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...